Nurix Therapeutics, Inc. logo

Nurix Therapeutics, Inc.

14 Marks
Corp.
First Filed:Sep 19, 2019Latest Filed:Oct 22, 2025Address:1600 Sierra Point Parkway, Brisbane, CA 94005, US

Portfolio Overview

Top Classes

Class 5
Pharmaceuticals
11(79%)
Class 42
Software, IT Services & Scientific Research
5(36%)

TTAB Proceedings

Total Proceedings
3
As Plaintiff
2(67%)
As Defendant
1(33%)

Top Firms

Loading...

Trademark Portfolio

14 results

(current & previous marks)

Refine by Mark/Description🔽
Filed
Registered
Last Activity
BEXKINVI
BEXKINVI
Trademark
Word
PENDING
Owner:
Serial:99457067
Filed:Oct 22, 2025
Classes:5
Description: Biological and pharmaceutical preparations for the treatment of cancer and immune-related disorders; biological and pharmaceutical preparations for the treatment of blood cancers, leukemia, lymphoma, and myeloma
DELBEXVI
DELBEXVI
Trademark
Word
PENDING
Owner:
Serial:99457072
Filed:Oct 22, 2025
Classes:5
Description: Biological and pharmaceutical preparations for the treatment of cancer and immune-related disorders; biological and pharmaceutical preparations for the treatment of blood cancers, leukemia, lymphoma, and myeloma
NUBEXVI
NUBEXVI
Trademark
Word
ABANDONED
Owner:
Serial:99457078
Filed:Oct 22, 2025
Classes:5
Description: Biological and pharmaceutical preparations for the treatment of cancer and immune-related disorders; biological and pharmaceutical preparations for the treatment of blood cancers, leukemia, lymphoma, and myeloma
REVBEXTI
REVBEXTI
Trademark
Word
PENDING
Owner:
Serial:99457070
Filed:Oct 22, 2025
Classes:5
Description: Biological and pharmaceutical preparations for the treatment of cancer and immune-related disorders; biological and pharmaceutical preparations for the treatment of blood cancers, leukemia, lymphoma, and myeloma
N
N
Trademark
Combined
PENDING
Owner:
Serial:98738218
Filed:Sep 6, 2024
Classes:5
Description: Biological and pharmaceutical preparations for the treatment of cancer and immune-related disorders; Research and development in the pharmaceutical and biotechnology fields
N
N
Service Mark
Combined
PENDING
Owner:
Serial:98978253
Filed:Sep 6, 2024
Classes:42
Description: Research and development in the pharmaceutical and biotechnology fields
NURIX
NURIX
Trademark
Combined
PENDING
Owner:
Serial:98978249
Filed:Sep 6, 2024
Classes:5, 42
Description: Class 5: Biological and pharmaceutical preparations for the treatment of cancer and immune-related disorders
Class 42: Research and development in the pharmaceutical and biotechnology fields
NURIX
NURIX
Trademark
Combined
PENDING
Owner:
Serial:98738213
Filed:Sep 6, 2024
Classes:5
Description: Biological and pharmaceutical preparations for the treatment of cancer and immune-related disorders; Research and development in the pharmaceutical and biotechnology fields
DELIGASE
DELIGASE
Service Mark
Word
REGISTERED
Owner:
Serial:88855023
Filed:Mar 31, 2020
Classes:42
Registration:6412399
Registered:Jul 6, 2021
Description: Research and development of biological and pharmaceutical drugs to treat diseases utilizing a proprietary drug discovery platform
NURIX
NURIX
Service Mark
Word
REGISTERED
Owner:
Serial:88723937
Filed:Dec 11, 2019
Classes:42
Registration:6090940
Registered:Jun 30, 2020
Description: Research and development in the pharmaceutical and biotechnology fields
NURIX
NURIX
Trademark
Word
REGISTERED
Owner:
Serial:88637426
Filed:Oct 1, 2019
Classes:5
Registration:6486938
Registered:Sep 14, 2021
Description: Biological and pharmaceutical preparations for the treatment of cancer and immune-related disorders
DE-CART
DE-CART
Trademark
Word
ABANDONED
Owner:
Serial:88622870
Filed:Sep 19, 2019
Classes:5
DETIL
DETIL
Trademark
Word
REGISTERED
Owner:
Serial:88622887
Filed:Sep 19, 2019
Classes:5
Registration:6918676
Registered:Dec 6, 2022
Description: Biological and pharmaceutical preparations for the treatment of cancer and immune-related disorders
NXACT
NXACT
Trademark
Word
REGISTERED
Owner:
Serial:88622881
Filed:Sep 19, 2019
Classes:5, 42
Registration:6521401
Registered:Oct 12, 2021
Description: Biological and pharmaceutical preparations for the treatment of cancer and immune-related disorders | Research and development in the pharmaceutical and biotechnology fields